The company's financial position remains vulnerable, characterized by a total debt load of $2.1B and a declining current ratio that tightened to 0.55 in 2026Q1.
| Total Current Assets | 1.45B | 895.54M | 903.96M | 97.02M | 85.1M | 756.56M | 70.92M | 11.05M |
| Cash & Short-Term Investments | 1.01B | 311.38M | 836.2M | 50.41M | 15.88M | 117.87M | 8.67M | 6.66M |
| Cash Only | 1.01B | 311.38M | 836.2M | 50.41M | 15.88M | 117.87M | 8.67M | 6.66M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 1.02M | 7.16M | 3.54M | 1.68M | 1.11M | 287K |
| Days Sales Outstanding | 64.47 | - | 0.73 | 5.2 | 2.02 | 1.13 | 6.7 | 1.76 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 449.68M | 584.16M | 66.74M | 24.59M | 37.38M | 250.35M | 59.93M | 1.41M |
| Total Non-Current Assets | 1.61B | 1.45B | 694.85M | 615.14M | 722.58M | 1.68B | 154.66M | 150.96M |
| Property, Plant & Equipment | 1.45B | 1.4B | 670.81M | 593.27M | 711.56M | 599.76M | 85.24M | 81.3M |
| Fixed Asset Turnover | 0.29x | 0.23x | 0.76x | 0.85x | 0.90x | 0.91x | 0.71x | 0.73x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 1.06B | 58.24M | 58.24M |
| Intangible Assets | 0 | 0 | 0 | 2.25M | 1.7M | 8.2M | 6.67M | 3.98M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 163.82M | 50.32M | 24.04M | 19.62M | 9.32M | 18.59M | 4.5M | 7.45M |
| Total Assets | 3.07B | 2.35B | 1.6B | 712.16M | 807.69M | 2.44B | 225.58M | 162.01M |
| Asset Turnover | 0.15x | 0.14x | 0.32x | 0.71x | 0.79x | 0.22x | 0.27x | 0.37x |
| Asset Growth % | 444.52% | 46.84% | 124.5% | -11.83% | -66.88% | 981.17% | 39.23% | - |
| Total Current Liabilities | 2.66B | 781.4M | 134.56M | 488.42M | 186.79M | 320.29M | 69.65M | 19.47M |
| Accounts Payable | 218.86M | 126.11M | 19.27M | 154.75M | 53.64M | 11.62M | 3.06M | 7.5M |
| Days Payables Outstanding | 238.8 | 163.73 | 18.05 | 149.06 | 30.98 | 13.87 | 21.91 | 55.89 |
| Short-Term Debt | 993.94M | 0 | 16.29M | 124.36M | 36.24M | 76M | 16.02M | 648K |
| Deferred Revenue (Current) | 430.86M | 127.56M | 18.13M | 9.83M | 78.19M | 141.93M | 0 | 0 |
| Other Current Liabilities | 1.23B | 527.73M | 69.23M | 6.78M | 1.64M | 4.39M | 47.49M | 8.69M |
| Current Ratio | 0.55x | 1.15x | 6.72x | 0.20x | 0.46x | 2.36x | 1.02x | 0.57x |
| Quick Ratio | 0.55x | 1.15x | 6.72x | 0.20x | 0.46x | 2.36x | 1.02x | 0.57x |
| Cash Conversion Cycle | -174.32 | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.71B | 2.53B | 2.28B | 820.67M | 1.03B | 777.37M | 22.23M | 6.69M |
| Long-Term Debt | 1.06B | 1.06B | 1.07B | 684.08M | 0 | 652.21M | 19.86M | 2.09M |
| Capital Lease Obligations | 92.23M | 0 | 97.85M | 37.26M | 720K | 62.15M | 2.26M | 3.18M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 651.82M | 1.47B | 1.11B | 99.33M | 1.03B | 63.01M | 103K | 1.41M |
| Total Liabilities | 4.38B | 3.31B | 2.42B | 1.31B | 1.22B | 1.1B | 91.88M | 26.16M |
| Total Debt | 2.06B | 1.06B | 1.2B | 865.54M | 37.73M | 818.81M | 40.29M | 7.49M |
| Net Debt | 1.05B | 748.95M | 363.57M | 815.14M | 21.85M | 700.93M | 31.62M | 837K |
| Debt / Equity | -1.57x | - | - | - | - | 0.61x | 0.30x | 0.06x |
| Debt / EBITDA | -43.68x | - | 11.89x | 8.21x | - | 4.09x | 13.10x | - |
| Net Debt / EBITDA | -22.32x | - | 3.60x | 7.73x | - | 3.50x | 10.28x | - |
| Interest Coverage | 5.50x | - | -34.45x | -1.85x | -21.34x | 2.42x | -1.75x | -49.73x |
| Total Equity | -1.31B | -962.74M | -820.18M | -596.94M | -409.35M | 1.34B | 133.7M | 135.85M |
| Equity Growth % | -689.61% | -17.38% | -37.4% | -45.83% | -130.52% | 903.15% | -1.59% | - |
| Book Value per Share | -4.04 | -3.03 | -3.21 | -1.57 | -1.20 | 5.75 | 0.35 | 0.36 |
| Total Shareholders' Equity | -1.31B | -962.74M | -820.18M | -596.94M | -409.35M | 1.34B | 133.7M | 135.85M |
| Common Stock | 3K | 3K | 3K | 36K | 36K | 27K | 1K | 1K |
| Retained Earnings | -4.49B | -4.15B | -3.74B | -2.42B | -2.17B | -27.43M | -74.74M | -62.54M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | -10.97M | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Negative equity and leverage
As reported in recent financial filings, Core Scientific's equity position has deteriorated to negative $1.3B in 2026Q1, reflecting a persistent trend of capital erosion that suggests the company's post-bankruptcy recovery remains fragile despite the expansion of its total asset base to $3.1B.
The consistent negative equity indicates that accumulated losses continue to outpace any capital injections or operational gains. This trajectory suggests that the company remains in a state of structural imbalance, where the scale of its infrastructure investment has yet to translate into a sustainable equity foundation.
Based on the latest quarterly data, Core Scientific carries $2.1B in total debt, a significant increase from the $1.1B reported in 2025Q4, which warrants close monitoring as the company attempts to leverage its infrastructure to generate returns in a highly competitive and volatile mining environment.
The rapid accumulation of debt suggests a reliance on external financing to fund capital-intensive infrastructure projects. Investors should consider whether this leverage is a strategic necessity for growth or a potential risk factor that could constrain future financial flexibility if mining margins remain compressed.
According to balance sheet disclosures, Core Scientific has grown its net property, plant, and equipment to $1.5B as of 2026Q1, highlighting a capital-heavy business model that prioritizes physical power capacity over liquid assets to secure a competitive position in the digital infrastructure market.
The concentration of assets in PPE underscores the company's transition toward a utility-like infrastructure provider. While this physical footprint is essential for operations, it also exposes the balance sheet to significant depreciation risks and the ongoing requirement for continuous capital reinvestment to maintain technological relevance.
As evidenced by the decline in the current ratio to 0.55 in 2026Q1 from 1.15 in 2025Q4, Core Scientific's liquidity buffer appears to be narrowing, which may limit the company's ability to absorb short-term operational shocks or unexpected fluctuations in energy and hardware costs.
A current ratio below unity suggests that current liabilities are outpacing current assets, which may indicate potential pressure on working capital management. This liquidity profile warrants further investigation into the company's ability to meet its near-term obligations without further dilutive financing or asset liquidation.
Financial statements reveal that the company's negative equity of $1.3B is compounded by a massive accumulated deficit of $4.5B, suggesting that headline asset growth may be masking deep-seated structural issues that could complicate future capital raising efforts or long-term solvency assessments.
The reliance on non-cash adjustments and the persistent deficit suggest that the company's balance sheet is heavily distorted by its historical financial distress. Analysts should be cautious, as the reported asset values may not fully account for the potential impairment risks inherent in specialized mining hardware.
Quick answers to the most common questions about buying CORZ stock.
As of 2025, Core Scientific, Inc. (CORZ) had total assets of $2.35B including $895.5M in current assets.
Core Scientific, Inc. (CORZ) carries total debt of $1.06B, offset by $311.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Core Scientific, Inc. (CORZ) has total shareholders' equity (book value) of $-962.7M ($-3.03 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Core Scientific, Inc. (CORZ) reported a current ratio of 1.15x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.